The Relationship of Omental and Subcutaneous Adipocyte Size to Metabolic Disease in Severe Obesity
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Several studies have reported the existence of a subgroup of obese individuals with normal metabolic profiles. It remains unclear what factors are responsible for this phenomenon. We proposed that adipocyte size might be a key factor in the protection of metabolically healthy obese (MHO) individuals from the adverse effects of obesity. SUBJECTS: Thirty-five patients undergoing bariatric surgery were classified as MHO (n = 15) or metabolically unhealthy obese (MUO, n = 20) according to cut-off points adapted from the International Diabetes Federation definition of the metabolic syndrome. Median body mass index (BMI) was 48 (range 40-71). RESULTS: There was a moderate correlation between omental adipocyte size and subcutaneous adipocyte size (r = 0.59, p<0.05). The MHO group had significantly lower mean omental adipocyte size (80.9+/-10.9 microm) when compared with metabolically unhealthy patients (100.0+/-7.6 microm, p<0.0001). Mean subcutaneous adipocyte size was similar between the two groups (104.1+/-8.5 microm versus 107.9+/-7.1 microm). Omental, but not subcutaneous adipocyte size, correlated with the degree of insulin resistance as measured by HOMA-IR (r = 0.73, p<0.0005), as well as other metabolic parameters including triglyceride/HDL-cholesterol ratio and HbA1c. Twenty-eight patients consented to liver biopsy. Of these, 46% had steatohepatitis and fibrosis. Fifty percent (including all the MHO patients) had steatosis only. Both omental and subcutaneous adipocyte size were significantly associated with the degree of steatosis (r = 0.66, p<0.0001 and r = 0.63, p<0.005 respectively). However, only omental adipocyte size was an independent predictor of the presence or absence of fibrosis. CONCLUSION: Metabolically healthy individuals are a distinct subgroup of the severely obese. Both subcutaneous and omental adipocyte size correlated positively with the degree of fatty liver, but only omental adipocyte size was related to metabolic health, and possibly progression from hepatic steatosis to fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Demographics ranging between men, women, and postmenopausal women show that there is a correlation between a beneficial phenotype for metabolic outcomes and subcutaneous fat accumulation, whereas visceral fat accumulation, including omental adipocyte hypertrophy, leads to a decline in metabolic health (20–25).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [23]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“However, larger adipocytes are positively correlated with adipose tissue macrophage number and production of pro-inflammatory cytokines TNF-a and IL-6 in mice[42].”
BackgroundAdipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · cited 1×
“‘two hit’ hypothesis for steatohepatitis[46].”
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Depot-related differences exist in adipocyte responses to lipolytic and lipogenic stimuli, in adipocyte apoptosis, expression of adipokine receptors, and secretion of adipokines[13,14,15,16].”
BackgroundIndependent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610 · cited 1×
“Recent studies indicate that the histological severity of NAFLD correlates with the indices of the metabolic syndrome, particularly degree of insulin resistance[40,41].”
BackgroundRelationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288 · cited 2×
“Large adipocytes are more likely to produce pro-inflammatory adipokines[12] and to demonstrate increased basal and catecholamine-stimulated lipolysis[24].”
BackgroundScherer, P. E. (2006) · Diabetes · doi:10.2337/db06-0263 · Cited by 1,066
Identification and characterization of metabolically benign obesity in humans
Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049 · cited 4×
“Other studies have investigated the factors responsible for protecting MHO individuals from developing co-morbidities such as diabetes and dyslipidemia[4,5,6].”
BackgroundInfluentialWeyer, C., Foley, J. E., Bogardus, C., Tataranni, P. A., & Pratley, R. E. (2000) · Diabetologia · doi:10.1007/s001250051560 · Cited by 799
Gender differences in fat metabolism
Blaak, E. (2001) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200111000-00006 · Cited by 709 · cited 1×
“women than in men, whereas free fatty acid release from the upper body depots is comparable[38].”
Background
Cited by
Items 101–200 of 210
Ontogenetic development of adipose tissue in grass carp (Ctenopharyngodon idellus)
Pin, L., Ji, H., Li, C., Tian, J., Wang, Y., & Yu, P. (2015) · Fish Physiology and Biochemistry · doi:10.1007/s10695-015-0053-x · Cited by 23
“In human beings, it is widely accepted that excessive development of WAT in the body leads to obesity as well as related metabolic diseases such as type 2 diabetes, cardiovascular disease (CVD), and some cancers (Flynn et al. 2006; Grundy 2004; O’Connell et al. 2010).”
BackgroundFaria, G. R., Pestana, D., Aral, M., Preto, J. R., Norberto, S., Calhau, C., Guimarães, J. T., & Taveira‐Gomes, A. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000686 · Cited by 23
de Sá, R. D. C. D. C., Simão, J. D. J., da Silva, V. S., Farias, T. M., Cruz, M. M., Antraco, V. J., Armelin‐Correa, L., & Alonso‐Vale, M. I. C. (2021) · Nutrients · doi:10.3390/nu13030754 · Cited by 23
Ananey, O. M., McLoughlin, B., Leonard, A., Maher, L., Gaffney, P. R., Boran, G. P., & Maher, V. M. G. (2015) · Journal of Physical Activity and Health · doi:10.1123/jpah.2014-0395 · Cited by 26
Faber, D. R., Moll, F. L., Vink, A., van der Waal, C., Kalkhoven, E., Schipper, H. S., Hajer, G. R., Monajemi, H., & Visseren, F. L. J. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.214 · Cited by 23
The impact of in utero heat stress and nutrient restriction on progeny body composition
Johnson, J. S., Abuajamieh, M., Sanz-Fernandez, M. V., Seibert, J. T., Stoakes, S. K., Keating, A. F., Ross, J. W., Selsby, J. T., Rhoads, R. P., & Baumgard, L. H. (2015) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2015.10.002 · Cited by 24
Cruz-García, E. M., Frigolet, M. E., Canizales‐Quinteros, S., & Gutiérrez‐Aguilar, R. (2022) · Nutrients · doi:10.3390/nu14224925 · Cited by 34
Kandhare, A. D., Bandyopadhyay, D., & Thakurdesai, P. A. (2018) · RSC Advances · doi:10.1039/c8ra05204b · Cited by 24
Gibert‐Ramos, A., Palacios-Jordan, H., Salvadó, M. J., & Crescenti, A. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-01930-9 · Cited by 24
Gómez‐Huelgas, R., Ruiz-Nava, J., Santamaria-Fernández, S., Vargas‐Candela, A., Alarcon-Martin, A. V., Tinahones, F. J., & Bernal-López, M. R. (2019) · Mediators of Inflammation · doi:10.1155/2019/4165260 · Cited by 20
“It has also been shown that the adipose tissue of MHO individuals has a favorable inflammatory profile associated with high levels of adiponectin [19].”
BackgroundIn vivo Metabolic Imaging of Insulin with Multiphoton Fluorescence of Human Insulin–Au Nanodots
Liu, C., Liu, T., Hsieh, T., Liu, H., Chen, Y., Tsai, C., Chen, H., Lin, J., Hsu, R., Wang, T., et al. (2012) · Small · doi:10.1002/smll.201201887 · Cited by 18
Transcriptional and epigenetic control of adipocyte remodeling during obesity
Barilla, S., Treuter, E., & Venteclef, N. (2021) · Obesity · doi:10.1002/oby.23248 · Cited by 22
“The evident feature of these metabolically healthy individuals with obesity is a higher number of small adipocytes in adipose tissue compared with metabolically unhealthy individuals with obesity (38).”
BackgroundYeh, C., Cheng, I.-C., Hou, Y., Wang, W., & Yeh, S. (2014) · PubMed · doi:10.6133/apjcn.2014.23.2.20 · Cited by 20
“A previous study showed that high level of visceral fat is an independent risk factor for glucose intolerance and insulin resistance,(11) whereas subcutaneous fat might not have a direct impact on metabolic dysfunction.(12) Our finding links miR-125a-3p with abdominal obesity and insulin resistance in men.”
BackgroundTan, J. T. M., Nankivell, V. A., Bilu, C., Shemesh, T., Nicholls, S. J., Zimmet, P., Kronfeld‐Schor, N., Brown, A. D. H., & Bursill, C. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246291 · Cited by 19
“Comparison studies of the two adipose depots showed that only visceral adipocyte size was related to metabolic health, increased macrophage recruitment and overall whole-body insulin resistance [54,55].”
BackgroundAdipose Tissue in Health and Disease
Leff, T., & Granneman, J. G. (2010) · Wiley eBooks · doi:10.1002/9783527629527 · Cited by 25
Gibert‐Ramos, A., Ibars, M., Salvadó, M. J., & Crescenti, A. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.04.005 · Cited by 24
Comparison of the Viability of Cryopreserved Fat Tissue in Accordance with the Thawing Temperature
Hwang, S. M., Lee, J.-S., Kim, H.-D., Jung, Y.-H., & Kim, H.-I. (2015) · Archives of Plastic Surgery · doi:10.5999/aps.2015.42.2.143 · Cited by 18
Does Carbon Dioxide Therapy Really Diminish Localized Adiposities? Experimental Study with Rats
Balık, O., Yılmaz, M., & Bağrıyanık, A. (2010) · Aesthetic Plastic Surgery · doi:10.1007/s00266-010-9638-z · Cited by 17
“5 statistical analysis program for calculation of the mean adipocyte diameter and the standard deviation for each sample (Table 1) [7, 8].”
MethodTorres‐Castillo, N., Martínez‐López, E., Vizmanos-Lamotte, B., & Garaulet, M. (2020) · Nutrients · doi:10.3390/nu13010119 · Cited by 22
“In addition, MHO subjects had smaller omental adipocytes than MUO subjects, which agrees with the findings of other studies [15,16].”
ResultAl-Jaber, H., Mohamed, N. A., Govindharajan, V. K., Taha, S., John, J., Halim, S., Alser, M., Almuraikhy, S., Anwardeen, N. R., Agouni, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911142 · Cited by 17
“In these studies, the large abdominal fat surface area was associated with an increased risk of insulin resistance, while the small size adipocytes was linked to the body’s insulin sensitivity [12], although the omental fat remains the only depot that correlates significantly with the metabolic syndrome [13].”
BackgroundMetabolically Healthy Obesity and Bariatric Surgery
Cătoi, A. F., & Busetto, L. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03964-8 · Cited by 23
GATA-3 as a Potential Therapeutic Target for Insulin Resistance and Type 2 Diabetes Mellitus
Al-Jaber, H., Al-Mansoori, L., & Elrayess, M. A. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200705210417 · Cited by 19
van Schothorst, E. M., Bunschoten, A., Verlinde, E., Schrauwen, P., & Keijer, J. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00042.2011 · Cited by 15
“Recently, a significant positive correlation was shown between omental adipocyte cell size and fatty liver in metabolically healthy, severely obese (26), suggesting, but not proving, that insulin sensitivity and insulin regulation in the omental adipocytes are of major impact.”
BackgroundWu, Z., Ma, Q., Cai, S., Sun, Y., Zhang, Y., & Yi, J. (2021) · Nutrients · doi:10.3390/nu13124480 · Cited by 17
Development and organization of omental milky spots
Okabe, Y. (2024) · Immunological Reviews · doi:10.1111/imr.13337 · Cited by 16
“10 In contrast, the omentum in mice is usually found as a thin, slightly elongated and vascularized fat attached to the stomach while it is | 69 OKABE structurally similar to human omentum.”
Immune Niche Within the Peritoneal Cavity
Okabe, Y. (2021) · Current topics in microbiology and immunology · doi:10.1007/978-3-030-86016-5_6 · Cited by 16
Tarantino, G., Barrea, L., Capone, D., Citro, V., Mosca, T., & Savastano, S. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00203 · Cited by 13
Turner, L., Gauthier, M., Lafortune, A., Tchernof, A., & Santosa, S. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01192-2 · Cited by 16
Jung, Y. J., Park, W. S., Nguyen, T. T., Kang, K. P., Jin, H. Y., Kim, S. H., Suh, W., & Kim, W. B. (2017) · Oncotarget · doi:10.18632/oncotarget.21998 · Cited by 12
“Omental adipocyte size has been shown to correlate with insulin resistance and metabolic parameters in obese individuals [6].”
BackgroundWohlers, L. M., Powers, B. L., Chin, E. R., & Spangenburg, E. E. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00617.2012 · Cited by 12
Evaluation of Ultrasound Combined with Chitosan for the Control of Weight and Local Fat in Mice
Liao, A., Ma, W.-C., & Wu, M. (2013) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2013.04.025 · Cited by 12
Sun, H., Fang, D., Wang, H., Wang, J., Yuan, Y., Huang, S., Ma, H., Gu, T., & Bi, Y. (2022) · Hepatology International · doi:10.1007/s12072-022-10409-5 · Cited by 12
“However, in extremely obese individuals, the association between adipocyte size and body mass index was reported to no longer existed [10, 11].”
BackgroundMelatonin decreases human adipose tissue insulin sensitivity
Zambrano, C., Garitaonaindia, M. T., Salmerón, D., Pérez‐Sanz, F., Tchio, C., Picinato, M. C., de Medina, F. S., Luján, J., Scheer, F. A. J. L., Saxena, R., et al. (2024) · Journal of Pineal Research · doi:10.1111/jpi.12965 · Cited by 10
“Since it is well known that visceral AT is much more associated with metabolic alterations than subcutaneous AT, 40 we studied the effect on both AT types separately and observed that melatonin decreased insulin sensitivity especially in visceral AT, which may be clinically relevant.”
InfluentialRegulation of ABCA1 and ABCG1 gene expression in the intraabdominal adipose tissue
Мирошникова, В. В., Пантелеева, А. А., Bazhenova, E., Demina, E. P., Usenko, T., Nikolaev, M. A., Semenova, I., Неймарк, А. Е., He, J., Belyaeva, О. D., et al. (2016) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20166203283 · Cited by 10
Seyfi, B., Fatouraee, N., & Samani, A. (2017) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2017.09.006 · Cited by 10
The color of fat and its central role in the development and progression of metabolic diseases
Gaggini, M., Carli, F., & Gastaldelli, A. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0060 · Cited by 12
“Adipocyte size might be implicated in the protection of MHO individuals from the adverse effects of obesity since hypertrophy of both subcutaneous and omental adipocytes was increased in T2D [82] and correlated with the degree of fatty liver and the risk of the progression from hepatic steatosis to fibrosis [83].”
BackgroundThe avian maternal environment: exploring the physiological mechanisms driving progeny performance
Angove, J. L., & Forder, R. E. A. (2020) · World s Poultry Science Journal · doi:10.1080/00439339.2020.1729675 · Cited by 13
“Furthermore increased adiposity may be a consequence of expanded adipocytes, a potential consequence of maternal stress, allowing for the accommodation of greater lipid quantities (O ’ Connell et al ., 2010).”
BackgroundNajafi, F., Pasdar, Y., Nazar, M. M., & Darbandi, M. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01630-4 · Cited by 11
“An increase in visceral fat and inflammation plays a significant role in NAFLD development, with those with the highest amount of visceral fat and the largest adipocyte diameter at the highest risk of developing NAFLD among obese individuals [15–20].”
BackgroundTop 10 Research Questions Related to Body Composition
Going, S. B., Lee, V. R., Blew, R. M., Laddu, D., & Hetherington‐Rauth, M. (2014) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.2013.875446 · Cited by 12
“…in the regulation of lipolysis (Van Pelt, Evans, Schechtman, Ehsani, & Kohrt, 2002), which contributes to differences in the cytokine profile (O’Connell et al., 2010; Wajchenberg, 2000), it is possible that increased subcutaneous fat may confer protective effects against metabolic…”
BackgroundJung, Y. J., Choi, H. J., Lee, J. E., Lee, A. S., Kang, K. P., Lee, S., Park, S. K., Park, T. S., Jin, H. Y., Lee, S., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.019 · Cited by 10
The metabolic syndrome: what’s in a name?
Matfin, G. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810374290 · Cited by 12
“Adipocyte hypertrophy (large adipocytes are more insulin resistant than smaller ones and secrete more pro-inflammatory adipocytokines) [O’Connell et al. 2010], visceral adiposity, and ectopic fat accumulation (this combination has been termed ‘adiposopathy’ or ‘sick fat’ by Bays in the US [Bays, 2009]) may result in t…”
BackgroundMa, X., Cao, M., Shen, Q., Yuan, J., Feng, T., Cheng, Q., Wang, X., Washabaugh, A. R., Baker, N. A., Lumeng, C. N.-K., et al. (2018) · Applied Sciences · doi:10.3390/app8112178 · Cited by 8
Ahmad, S., Drag, M., Salleh, S. M., Cai, Z., & Nielsen, M. O. (2021) · BMC Genomics · doi:10.1186/s12864-021-07672-5 · Cited by 10
Adipose Y5R mRNA is higher in obese than non-obese humans and is correlated with obesity parameters
Chatree, S., Sitticharoon, C., Maikaew, P., Uawithya, P., & Chearskul, S. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370218774889 · Cited by 11
Narankiewicz, D., Ruiz-Nava, J., Buonaiuto, V. A., Ruiz-Moreno, M. I., Lopez-Carmona, M. D., Perez-Belmonte, L. M., Gómez‐Huelgas, R., & Bernal-López, M. R. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17103518 · Cited by 7
“Among subjects with obesity, those with the highest amount of visceral fat [7] and those whose adipocytes are largest in diameter [8] are those at highest risk for NAFLD.”
BackgroundSteiner, B. M., Benvie, A. M., Lee, D., Jiang, Y., & Berry, D. C. (2024) · Nature Communications · doi:10.1038/s41467-024-50985-8 · Cited by 8
“To continue to explore the link between ERa and Cxcr4, we performed siRNA ERa knockdown experiments in female control and mutant APCs and evaluated adipogenesis.”
He, X., Guan, H., Liang, W., Huang, Z., Xu, L., Zhang, P., Xu, F. L., & Li, Y. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0024-2 · Cited by 8
“More and more study confirmed that omental adipocyte hypertrophy could independently predict stages of NAFLED [21, 22].”
BackgroundCandi, E., Campanelli, M., Sica, G. S., Schinzari, F., Rovella, V., Daniele, N. D., Melino, J., & Tesauro, M. (2021) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2020.100077 · Cited by 11
Ahmad, S., Lyngman, L. K., Mansouryar, M., Dhakal, R., Agerholm, J. S., Khanal, P., & Nielsen, M. O. (2020) · Physiological Reports · doi:10.14814/phy2.14600 · Cited by 9
“This challenges a previous assumption that adipose tissue growth during most of postnatal life occurs by hypertrophy of existing adipocytes (Chusyd et al., 2016; Fang et al., 2015; Foster et al., 2011; Karastergiou et al., 2012; Lamacchia et al., 2011; Lim & Meigs, 2014; McLaughlin et al., 2014; O'Connell et al., 2010…”
BackgroundInfluentialJohnson, J. S. (2014) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-3204 · Cited by 7
Alradi, M., Askari, H., Shaw, M., Bhavsar, J., Kingham, B. F., Polson, S. W., & Fancher, I. S. (2024) · Physiological Genomics · doi:10.1152/physiolgenomics.00080.2024 · Cited by 7
Regulation of ABCA1 and ABCG1 transporter gene expression in the intraabdominal adipose tissue
Мирошникова, В. В., Пантелеева, А. А., Bazhenova, E., Demina, E. P., Usenko, T., Nikolaev, M. A., Semenova, I., Неймарк, А. Е., He, J., Belyaeva, О. D., et al. (2016) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s199075081604003x · Cited by 6
Ott, F., Körner, C., Werner, K., Gericke, M. T., Liebscher, I., Lobsien, D., Radrezza, S., Shevchenko, A., Hofmann, U., Kratzsch, J., et al. (2022) · Cells · doi:10.3390/cells11101680 · Cited by 6
“The expansion in a hyperplastic manner that is observed in MHO is accompanied by a higher proportion of relatively small adipocytes in the adipose tissue [50,51].”
BackgroundRETRACTED ARTICLE: Adipose stromal-vascular fraction-derived paracrine factors regulate adipogenesis
Liu, M., Guo, L., Liu, Y., Pei, Y., Li, N., Jin, M., Ma, L., Li, Z., Sun, B., & Li, C. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1820-6 · Cited by 8
RetractedDonovan, E. L., Buckels, E. J., Hancock, S. N., Smeitink, D., Oliver, M. H., Bloomfield, F. H., & Jaquiery, A. L. (2016) · Reproductive Sciences · doi:10.1177/1933719116670516 · Cited by 6
“It is now widely accepted that visceral adiposity and adipose phenotype have mechanistic links to the pathology of insulin resistance and diabetes.(16) Increased adipocyte number and size may affect adipocyte inflammation, adipocyte insulin signaling, and systemic insulin resistance.”
BackgroundInfluentialPincu, Y., Makarenkov, N., Tsitrina, A. A., Rosengarten-Levin, M., Haim, Y., Yoel, U., Liberty, I. F., Dukhno, O., Kukeev, I., Blüher, M., et al. (2023) · Obesity · doi:10.1002/oby.23899 · Cited by 8
“However, such as in SAT, larger VAT adipocytes are associated with metabolic dysfunction [7 – 9].”
BackgroundWang, Y., Yu, Z.-F., Cheng, Y., Jia, B., Yu, G., Yin, X., & Wang, Y. (2017) · Medicine · doi:10.1097/md.0000000000007498 · Cited by 5
“It is also proved that severe obesity contributes to fatty liver and metabolic disturbances; several factors, including insulin sensitivity, blood pressure, as well as plasma lipid profile, are associated with excessive accumulation of fat in visceral adipose tissue (VAT), resulting in dyslipidemia, damaged glucose to…”
BackgroundTang, J., Cai, X., Liu, A., Yu, N., & Wang, S. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01579-4 · Cited by 4
“Increased visceral fat in obese teens is linked to impaired lipogenic or adipogenic capacity [19], and lower omental adipocyte size in obese adults is linked to metabolic health [20].”
BackgroundSitticharoon, C., Boonpuan, V., Mitrpant, C., & Churintaraphan, M. (2017) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
Carrascoza, V. S. R., Garcia, R. F., Gargaro, L. L., Pedrosa, M. M. D., Brito, N. D. A., Salgueiro‐Pagadigorria, C. L., & Brito, M. D. N. (2019) · Journal of Pharmacy and Pharmacology · doi:10.17265/2328-2150/2019.03.002 · Cited by 3
Bartušková, H., Lesná, I. K., Kauerová, S., Lánská, V., Froněk, J., Janoušek, L., Muffová, B., Paukner, K., & Poledne, R. (2025) · Adipocyte · doi:10.1080/21623945.2025.2499500 · Cited by 3
“The association between adipocyte size and IR has been previously reported in omental and mesenteric VAT and SAT [11,30,31,37].”
Byun, K.-A., Kim, H. M., Oh, S., Batsukh, S., Lee, S., Oh, M., Lee, J., Lee, R., Kim, J. W., Oh, S. M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147648 · Cited by 5
“This approach allowed us to accurately identify the thermal lesion without being influenced by other factors such as movement (Figure S1).”
BackgroundYamada, T., HIGUCHI, M., & NAKANISHI, N. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.036 · Cited by 3
Tahergorabi, Z., Rashidi, B., & Khazaei, M. (2013) · Europe PMC (PubMed Central) · Cited by 3
Seip, R. L. (2012) · CRC Press eBooks · doi:10.1201/b12085-20 · Cited by 3
Wolf, D., Jehle, F., Rodríguez, A. O., Dufner, B., Hoppe, N., Colberg, C., Lozhkin, A. P., Bassler, N., Rupprecht, B., Wiedemann, A., et al. (2012) · PLoS ONE · doi:10.1371/annotation/84102aae-770a-41ae-9c15-4736ed129c17 · Cited by 3
Chen, Z., Liu, T., Huang, P., Liu, Y., Xu, S., Ding, J., Song, H., Yang, L., & Zheng, P. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177874 · Cited by 2
Yildiz, M., Bozkurtlar, E. B., Azizy, A., & Ağırbaşlı, M. A. (2019) · Autopsy and Case Reports · doi:10.4322/acr.2019.121 · Cited by 2
Shehat, M. G., Miller, M. H., Calder, A. N., Gilbertson, T. A., & Tigno-Aranjuez, J. T. (2023) · Innate Immunity · doi:10.1177/17534259231193926 · Cited by 2
“The most well-studied pathway and receptor found to mediate HFD-induced inflammation is NF-κB activation induced through Toll-like receptor 4 (TLR4) engagement.13,14 Initial studies seemed to indicate that dietary FAs themselves (particularly long chain SFAs) could directly signal through this receptor.15,16 More rece…”
ResultInfluentialAnatomy and Physiology of Adipose Tissue
Huang, Y., Hu, Y., Chen, H., Cai, Z., & He, B. (2024) · Contemporary Endocrinology · doi:10.1007/978-3-031-72570-8_2 · Cited by 2
youshari, N., Ebrahimi‐Mameghani, M., Jafarabadi, M. A., Youshari, N., & Poor, M. L. (2016) · journal of ilam university of medical sciences · doi:10.18869/acadpub.sjimu.24.3.79 · Cited by 2
Cao, M., Zhu, Y., O’Rourke, R. W., Wang, H., Yuan, J., Cheng, Q., Xu, G., Wang, X., & Carson, P. L. (2017) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2250674 · Cited by 2
“Previous research has proved that adipocyte size is correlated with metabolic disease risk in the form of DM [12].”
BackgroundThe role of Ad-36 and its E4orf-1 protein in modulating glycemic control
Dhurandhar, E. J. (2011) · Louisiana State University · doi:10.31390/gradschool_dissertations.1411 · Cited by 3
Andele, P. K., Palazzolo, S., Corona, G., Caligiuri, I., Kamenšek, U., Čemažar, M., Canzonieri, V., & Rizzolio, F. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304206 · Cited by 1
Abdominal Adipose Tissue Fibrosis as an Obesity Biomarker in Clinical Practice
Zorzano-Martínez, M., Pallarés, J. G., Bueno, M., Salinas‐Roca, B., Buenaventura-Collazos, D. C., Hernández, C., Simó, R., & Lecube, A. (2026) · Obesity Facts · doi:10.1159/000550517 · Cited by 1
Giant Mice Reveal New Roles for GH in Regulating the Adipose Immune Microenvironment
Odle, A. K., Drew, P. D., & Childs, G. V. (2015) · Endocrinology · doi:10.1210/en.2015-1205 · Cited by 1
Bu, S. Y. (2015) · The Korean Journal of Food And Nutrition · doi:10.9799/ksfan.2015.28.1.084 · Cited by 1
Photoacoustic Tomography (PAT)
Wang, X., Yang, X., & Deán‐Ben, X. L. (2021) · MDPI eBooks · doi:10.3390/books978-3-03943-644-6 · Cited by 1
Moreno, F. N., Gilglioni, E. H., Garcia, R. F., Lucredi, N. C., Ferreira, S. M., Brito, N. A., Brito, M. D. N., Ishii‐Iwamoto, E. L., & Salgueiro‐Pagadigorria, C. L. (2019) · Journal of Pharmacy and Pharmacology · doi:10.17265/2328-2150/2019.04.001 · Cited by 1
“reported for comparisons of lean premenopausal and obese postmenopausal women [2], as well as for comparisons of healthy and unhealthy, severely obese men [3].”
BackgroundPhenotypic classification and biochemical profile of obesity for cardiovascular prevention
Perrone, M. A., Dasari, J. B., Intorcia, A., Gualtieri, P., Marche, M., Luozzo, M. D., Merra, G., Bernardini, S., Romeo, F., & Sergi, D. (2020) · Gazzetta Medica Italiana Archivio per le Scienze Mediche · doi:10.23736/s0393-3660.20.04259-x · Cited by 1
Liu, M., Guo, L., Liu, Y., Pei, Y., Li, N., Jin, M., Ma, L., Li, Z., Sun, B., & Li, C. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2612-y · Cited by 1
RetractedVitamin D, Inflammation, and Relations to Insulin Resistance in Morbidly Obese Pre-Menopausal Women
Nguyen, V. T. (2013) · Figshare
The Biology of Aging: Role in Cancer, Metabolic Dysfunction, and Health Disparities
LeBrasseur, N. K., Huffman, D. M., & Denis, G. V. (2014) · Springer eBooks · doi:10.1007/978-3-319-06103-0_5
Bad Fat or Just More Fat? Murine Models of Metabolically Healthy Obesity
Bennett, G., Greenberg, A. S., & Obin, M. S. (2014) · Humana Press eBooks · doi:10.1007/978-1-62703-770-9_4 · Cited by 1
Effects of Chronic Insulin and High Glucose on Insulin-Stimulated Responses in Human Preadipocytes
Bilali, J. E. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-5962
Human Adipocytes : Proteomic Approaches
Jufvas, Å. (2016) · Linköping University medical dissertations · doi:10.3384/diss.diva-125907
Regulation of adipogenesis and inflammation: role(s) of adipose microRNAs
Al-Jabir, M. J. M. H. (2016) · UCL Discovery (University College London)
Ide, J. C. (2011) · Library and Archives Canada (Government of Canada) · doi:10.20381/ruor-4408
“proximity to the liver, making it possible for the products from the visceral adipocytes to drain into the portal vein (O'Connell et al., 2010).”
BackgroundANÁLISE DA FIBROSE DO TECIDO ADIPOSO DE MULHERES SUBMETIDAS À ABDOMINOPLASTIA E CIRURGIA BARIÁTRICA
Errera, F. I. V., Nogueira, B. V., & Nahas, F. X. (2014)
Characterisation of the relationship between Heme-oxygenase-1 and adiponectin
Yang, M. (2017) · The University of Queensland · doi:10.14264/uql.2017.865
Fetuin-A: a novel marker for obesity and associated comorbidities
Robinson, K. N. (2017) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Tibolone Reverses NAFLD in Ovariectomised Rats by Reducing Adiposity and Insulin Resistance
Campos-Shimada, L. B., Gilglioni, E. H., Hermoso, D. A. M., Buzzo, A. J. D. R., Garcia, R. F., Martins-Maciel, E. R., Ishii‐Iwamoto, E. L., & Salgueiro‐Pagadigorria, C. L. (2019) · Journal of Pharmacy and Pharmacology · doi:10.17265/2328-2150/2019.04.002
“including overproduction of TNF-α [5, 7], and higher”
InfluentialAdipocyte size in morbidly obese women and its relation to type 2 diabetes
Kamarád, V., Chylíková, J., Dvorackova, J., Cizkova, K., & Lacey, H. (2019) · Acta Medica Martiniana · doi:10.2478/acm-2019-0006
“The enlargement of adipocytes found in the obese is well known (2,11,12,13), and a difference in size of subcutaneous and visceral adipocytes has also been reported (5,10,11,12,14,15,16).”
BackgroundEffects of Exercise on Factors Regulating Adipose Tissue Expandability
Ludzki, A. C. (2020) · Deep Blue (University of Michigan)
Al-Jaber, H., Mohamed, N. A., Govindharajan, V. K., Taha, S., John, J., Halim, S., Alser, M., Almuraikhy, S., Anwardeen, N. R., Agouni, A., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1646980/v1
Ceramide as a Biomarker for HFpEF in Women: Menopause, Aging, and Pregnancy
Magaye, R., Kaye, D. M., & Wang, B. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110800 · Cited by 1
Origins and consequences of altered metabolic processes in obese pregnant women
Barr, S. M. (2013) · ERA
Tang, J., Cai, X., Liu, A., Yu, N., & Wang, S. (2024) · Figshare · doi:10.6084/m9.figshare.25632885
Metadata
- Authors
- O'Connell, J., Lynch, L., Cawood, T. J., Kwasnik, A., Nolan, N., Geoghegan, J., McCormick, A., O'Farrelly, C., & O'Shea, D.
- Affiliations
- St. Vincent's University Hospital (IE)
- Christchurch Hospital (NZ)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-04-01
- Volume
- 5
- Issue
- 4
- Pages
- e9997
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2848665
- OpenAlex
- W2115664664
- Cited by
- 211
- References
- 47
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 11 · 2023: 4 · 2022: 14 · 2021: 14 · 2020: 19 · 2019: 16 · 2018: 11 · 2017: 11 · 2016: 16 · 2015: 18 · 2014: 19 · 2013: 18 · 2012: 9
- FWCI
- 11.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
- Funders
- Medical Research Charities Group
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- metabolically healthy obesity, omental adipocytes, subcutaneous adipocytes, adipocyte size, morbid obesity, insulin resistance, hepatic steatosis, liver fibrosis, steatohepatitis, bariatric surgery, metabolic syndrome, HOMA-IR
- MeSH terms
- Adult, Fatty Liver, Female, Humans, Insulin Resistance, Male, Metabolic Diseases, Middle Aged, Omentum, Body Mass Index, Adipocytes, Metabolic Syndrome, Cell Size, Subcutaneous Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.